Cart
sales@molnova.com
RN-1665
CAS No. 1803003-65-7
RN-1665( —— )
Catalog No. M37081 CAS No. 1803003-65-7
RN-1665 is a potent and selective TRPV4 receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 157 | In Stock |
|
| 10MG | 216 | In Stock |
|
| 25MG | 357 | In Stock |
|
| 50MG | 463 | In Stock |
|
| 100MG | 637 | In Stock |
|
| 200MG | 840 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRN-1665
-
NoteResearch use only, not for human use.
-
Brief DescriptionRN-1665 is a potent and selective TRPV4 receptor antagonist.
-
DescriptionRN-1665 is a potent and selective TRPV4 receptor antagonist.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRP/TRPV Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1803003-65-7
-
Formula Weight513.54
-
Molecular FormulaC20H24F5N3O3S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=C(S(N2CCN(C(C)C)CC2)(=O)=O)C=C1)C3=CC=C(S(F)(F)(F)(F)F)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Elismetrep
Elismetrep (MT-8554) is an orally available TRPM8 inhibitor with potential analgesic activity for the study of vasomotor symptoms in postmenopausal women.
-
LASSBio-1135
LASSBio-1135 is an orally effective antagonist of TRPV1 and inhibitor of TNF-α production.Oral administration of 100 mol x Kg(-1) LASSBio-1135 markedly reduced thermal hyperalgesia induced by carrageenan.
-
AMTB hydrochloride
AMTB is a novel TRPM8 channel blocker and is effective for pain and urinary diseases.
